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in RESTORE (tirofiban + haparin vs haparin alone x 36 hrs. post PTCA).
The frames for dye to reach standardized distal landmarks were counted to
arrive at the previously described Corrected TIMI Frame Count (CTFC), an
index of coronary flow. Previously, normal non-culprit arteries in the absence
of an acute coronary ayndrome have been shown to have a CTFC of 21
+ 3.1 with an upper bound of the 95% confidence interval for normal flow
of 27 frames. If pre-PTCA flow in the culprit artery was abnormal (CTFC >
27 frames) than flow in tha non-culprit was also abnormally slowed (30.0 +
15.1 frdmes, n = 702 vs 22.5 & 10.4, n = 516, p < 0.0001). Similarly, pts.
with TIMI Grade 3 flow in their culprit artary had faster non-culprit flow than
pte. with TIMI Grade 2 culprit flow (23.4+ 11.3, n = 719, vs 27.6 + 13.4, n
. 1166, p < 0.0001). When examined from the opposite perspective, 36%
of non-culprit arteries had abnormal pre-PTCA flow (i.e. CTFC > 27), and
the flow in the aasociatad culprit artery was slower (42.3 + 23.2, n = 455,
vs 31.9 + 21.4, n = 763, p < 0.0001). Non-culprits with abnormal CTFCS
(>27) pre PTCAimprovad significantly post PTCA (A 9.6 + 19.7, n = 54, p =
0.0006, despite no A in catheter size) & improved to a greater degrea (p <
0.0001) than non-culprits with a pre PTCA CTFCs 27 which did not change
significantly. Conclusions: Culprit &non-culprit artery flows are interrelated in
acute coronary syndromea. If culprit artery flow is slow, then the associated
non-culprit flow is also slowad. Non-culprit artaries with abnormal flow pre
PTCA improve following PTCA of the culprit artery.
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El9037 ReperfusionTherapyin PostCoronaryArteryBypaaaGraftPatientswithMyocardialInfarction:
ClinicalExperiencefromtheNationalRegistryof
Myocardialinfarction-2
L.R. Petereon, N. Chandra, W.J. French, W.J. Rogers, D. Weaver,
A.J. Tiefenbrunn. kVaahingfonUniversity Scfroo/ofMediCiffe, .9. Louia, MO,
USA
Reperfusion therapy in post-CABG patients (pts) with Ml has not been widely
studied. To determine outcomes in pts who were post-CABG with acute Ml,
data from the National Registry of Myooardial infarction-2 were reviawad. Of
24,339 l~ic eligible pts with ST elevation or LBBB who were not in shock
and treated within 12 hr of Ml onset, 1,492 (6.1%) had prior CABG. of these,
1,320 (68.5Yo) received IV alteplase (rt-PA) and 172 (11.5%) underwant
primary angiopiaety (PTCA).
ComDaradto rt-PA pts without CABG, peat-CABG pte were older (64.6vs
60.7 yr)j more likely male (78% vs 70%), with higher rates of prior Ml (57%
vs ls~o), CHF (7.5~o vs 3.2~0),andStroke(4.5Y0vs 2.8~o)iall P <0.001. For
pte receiving rt-PA, unadjusted hospital mortality was 7.9% in CABG pts vs
5.2% in pts without CABG (p < 0.001).
The post-CABG pts treated by PTCA were similar to peat-CABG pts
treated with rI-PA and had similar mortality (11.0% after PTCA vs 7.9% after
rt-PA, p = NS). For pte treatad with PTCA, unadjusted mortality wee higher
in peat-CABG pts than in pta without CABG (11.0% vs 5.0%, respectively,
p < 0.001). Stepwise logistic regression analysis identified prior CABG as
a pradiotor of mortality (OR 1.43, 95% Cl 1.15-1.77), but not repeffusion
modality.
Thus, post-CABG pts with acute Ml have a higher mortality than non-
CABG DtesimiiarlYtraated. Mortality in post-CABG pts with Ml does not diffar
El9038 CardiogenicShockDevelopingWithin48HoursAfterThrombolysisforAcuteAnteriorMyocardial
infarctionmaybeRelatedto HemorrhagicCardiac
TamponadeWithoutRupture
J. Renkin, M. Carlier, P. De Man, K. Al Shwafi, F.Van de Werf, J. Col.
University of Louvain, Brussels, Belgium, Univareity of LOuvairr,Leuven,
Belgium
Cardiogenic shock (CS) is the first cause of death following acute myocardial
infarction (AMI) irrespective of its time of onset. Thrombolytic therapy (TH)
wasassociatedwith an increased number of early daaths posaibly related to
a higher incidance of cardiac rupture. We observed 11 patients (pts), mean
age 64+ 7, Killip class 1, when admitted within 6 + 4 hours (h) of symptoms
onsetfora large anterior AMl with STelevation developing CS within 48 hours
of TH. TH was anistreplase (n = 1), streptokinase (n = 3) or alteplase (n = 7)
all with heparin (n= 9) or hirudin (n= 2) and aspirin (n= 11).After echocardio-
graphy confirmad pericardial effusion without evidence for myocardial (sub)
acute rupture, emergency percutaneous pericerdiocentesis was performad
at bedsida 34 + 24 h after TH, allowing to rapidly reverse CS in each case.
Continuous drainage using intrapericardial catheter was maintained in 10 pte
for a mean period of 52 + 33 h and removed moderate to large amounts of
hemorrhagic fluid (range 280-4515 ml). In each case angiography showad
a P’dtentinfarct related left anterior descending coronary artery and major
LV dysfunction (mean ejection fraction at 32 + 8%). At 1 month the survival
rate was 91%. In conclusion, cardiac tamponade is not necessarily related
to myocerdial rupture and is a reversible cause of aarly CS after TH. Large
anterior Ml and full anticoagulation are favoring factors. Although the precise
incidence of this complication is unknown, its recognhion contributes to limit
mortality in CS since appropriate pericardiocentesis appaare life saving.
_/ StentAssisted~ire~tBalloonAn9ioPlastYforA~ute
MyocardialInfarction,ClinicalandAngiographic
Follow-up
Y.Nakagawa, H. Nosaka, T. Kimura, T. Tamura, H. Yokoi, N. Hamasaki,
M. Nobuyoshi. Kokura Memorial Hospital, Kitakyusfw, Japan
To confirm mid-term efficacy and safety of stenting for acute myoeardial in-
farction (AMI), follow-up angiography (FUA) was performed. AMI patients
(pts) under 80 years of age were prospectively treated with ‘Stent assisted
Direct Balloon Angioplasty (DBA)’. DBA was attempted in all AMI pte. When
the result of DBA was unsatisfactory, stenting was performed subsequently.
Of the 111pte treated, 85 pts (77%) received DBA alone and 63 pts (98%)
achieved successful reperfusion. The rest of 26 pts (23%) received suc-
cessful stenting. Overall successful reparfusion rate was 83 +26/111 =96%.
Three weeks FUAwas performed in 109 pts (100% of eligible) and it revealed
2 restenosis, including 1 reocclusion, after DBA alone and no restenosis af-
ter stent. Four months FUA was performed in 99 pts (gs~o of eligible) and it
revealad 20 restenosis (27%), including 1 reocclusion, attar DBA alone and
2 restenoaia(8.3%) without raocclusion after stent. Overall patenoy rate was
99% and restanosis rate was 22%. During this follow-up, thera wee no major
cardiac event and target leSiOn revascularization rate was 17Y0.Referenoe
lumen diameter was larger in stented pts (P= NS). Post procedure minimal
Iuman diameter (MLD) was significantly larger in stentad pte than in DeA
alona pts, and this difference was maintained during follow-up.
MLD(mm) Reference Pre-stent Post 4 Mos
DBA alone 2.88+ 0.83 (NS) 2.1S + 0.44 (S 0.01) 1.87+ 0.84 (S 0.01)
Stent 3.11 + 0.75 (NS) 1.50 i 0.63 2.94* 0.54 (s 0.01) 2.23 +0.72 (s 0.01)
All 2,94 + 0.88 2.13 + 0.57 2.30 + 0.78
In conclusion; stenting for suboptimal result of DBA had favorable effect
to restora and suetain patency with extraordinary high rate of 99% aven at 4
months.
D90310 ClinicalandAngiographicOutcomeofIntracoronaryStentPlacementinAcuteMyocardial
Infarction
H, Walter, F.-J. Neumann, M. Hadamitzky, H. Schuhlen, A. Wehinger,.
J. Hausleiter, N. Mazzilli, J. Dirschinger, A. Schbmig. L Medizirrische K/ini/r,
Klinikum rechts derlsar, Germany, Deutsches Herzzentrum, Techniache
Universitdt Munchen, Germany
The present prospective follow-up study summarizes the experience in pa-
tients with coronary artery stent placement for acute myocardial infarction
(Ml) without postprocedural anticoagulant therapy.
By the end of July 96, 231 patients with stent placement in acute Ml
not implicated by cardiogenic shock or mechanioel ventilation prior to the
intervention had been enrolled. The antiplatelet protocol consists of aspirin
100 mg bid + ticlopidine 250 mg bid. Cardiac events and major non cardiac
avents were assessed. The cardiac event rate (death, repaat myooardial
infarction, stant vessel occlusion, CABG, repeat PTCA) during 30 day follow-
UPwas 3.5%. The rate of death or repeat myocerdial infarction was 1.3Y0,
stent occlusion rate was 1.3% and the percentage of repeat interventions
was 3.0%.
117 patients were eligible for 6 months follow-up by August 96. Suwival
rate free of repeat Ml was 94.1%, the rate of repeat interventions was 17.1%.
Repeat angiography was performad in 86.7% of the patienta. Angiographic
data ware evaluated by an automated and computer assisted edge detection
method. Restenosis (diameter stenosis 250%) was present in 27.8% of the
patients.
These preliminary data suggest that stenting in acute myocardial infarction
is feasible and safe with an excailent Iongterm outcoma.
